Global Animal-derived Heart Valves Market Growth 2025-2031

The global Animal-derived Heart Valves market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Animal-derived heart valves, also known as xenograft heart valves, are heart valve replacements or prosthetics that are made from tissues harvested from animals, typically pigs (porcine) or cows (bovine). These valves are used to replace damaged or diseased heart valves in humans, particularly in cases where a person"s own heart valve is no longer functioning properly.

The animal-derived heart valves are typically made from the valve leaflets or pericardium. The valve leaflets are often cross-linked to improve durability and mechanical properties. The animal tissues, such as heart valve leaflets or pericardium, undergo thorough processing and sterilization to remove cellular and antigenic components, minimizing the risk of immune rejection. Animal-derived heart valves are considered biocompatible, meaning they are well-tolerated by the human body and integrate effectively with the surrounding tissues after implantation.

Animal-derived heart valves are surgically implanted to replace damaged or malfunctioning heart valves. They can replace either the aortic valve or the mitral valve, depending on the patient"s condition. Animal-derived heart valves are readily available, and the surgery for implantation is well-established. They have good hemodynamic performance and can last for a significant period.

United States market for Animal-derived Heart Valves is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Animal-derived Heart Valves is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Animal-derived Heart Valves is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Animal-derived Heart Valves players cover Edwards Lifesciences, Medtronic, Abbott, Boston Scientific Corporation, Livanova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Animal-derived Heart Valves Industry Forecast” looks at past sales and reviews total world Animal-derived Heart Valves sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal-derived Heart Valves sales for 2025 through 2031. With Animal-derived Heart Valves sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal-derived Heart Valves industry.

This Insight Report provides a comprehensive analysis of the global Animal-derived Heart Valves landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal-derived Heart Valves portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal-derived Heart Valves market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal-derived Heart Valves and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal-derived Heart Valves.

This report presents a comprehensive overview, market shares, and growth opportunities of Animal-derived Heart Valves market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Aortic Valve
Mitral Valve

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific Corporation
Livanova
Jenavalve Technology
Colibri Heart Valve
CryoLife
Labcor Laboratorios
Balance Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Animal-derived Heart Valves market?

What factors are driving Animal-derived Heart Valves market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Animal-derived Heart Valves market opportunities vary by end market size?

How does Animal-derived Heart Valves break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.